Changes in Metabolic Parameters in Patients with Diabetic Kidney Disease Depending on the Status of D3

Overview

Journal Rev Recent Clin Trials

Specialties General Medicine
Pharmacology

Date 2022 Mar 23

PMID 35319388

Authors

Yulia Pastukhova

Francesco Luzza

Sviatoslav Shevel

Oleksii Savchuk

Liudmyla Ostapchenko

Tetyana Falalyeyeva

Nataliia Molochek

Olena Kuryk

Oleksandr Korotkyi

Nazarii Kobyliak

Affiliations

Soon will be listed here.

Abstract

Background: Type 2 diabetes is a metabolic disease characterized by hyperglycemia as a result of insulin resistance and decreased insulin secretion. A relatively large number of patients with this type of diabetes have abdominal obesity, which also affects insulin resistance development. Chronic hyperglycemia can lead to damage and dysfunction of various organs, and a striking example is diabetic nephropathy. Diabetic nephropathy is a specific kind of kidney damage that occurs due to complications of diabetes and is accompanied by the formation of diffuse or nodular glomerulosclerosis, which can lead to terminal renal failure and requires immediate substitution through renal therapy or renal transplantation. Diabetic nephropathy is diagnosed with albuminuria and a decrease in the rate of glomerular filtration.

Methods: This review was based on a literature search for the most important evidence of vitamin D as a possible method of prevention for obesity, type 2 diabetes, and diabetic nephropathy. Collected published articles were summarized according to their overall themes.

Results: In this review, we considered vitamin D as a possible method of treatment for type 2 diabetes, as well as its complications, including diabetic nephropathy.

Conclusion: Studies show that vitamin D inhibits the renin-angiotensin-aldosterone system, resulting in improved renal function in diabetic nephropathy. Vitamin D also has antiinflammatory, antiproliferative, and anti-metastatic effects, which improve endothelial function.

Citing Articles

Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies.

Darenskaya M, Kolesnikov S, Semenova N, Kolesnikova L Int J Mol Sci. 2023; 24(15).

PMID: 37569752 PMC: 10419189. DOI: 10.3390/ijms241512378.

References

Berridge M . Vitamin D deficiency accelerates ageing and age-related diseases: a novel hypothesis. J Physiol. 2017; 595(22):6825-6836. PMC: 5685827. DOI: 10.1113/JP274887. View

Pike J, Christakos S . Biology and Mechanisms of Action of the Vitamin D Hormone. Endocrinol Metab Clin North Am. 2017; 46(4):815-843. PMC: 5762112. DOI: 10.1016/j.ecl.2017.07.001. View

Wyskida M, Wieczorowska-Tobis K, Chudek J . Prevalence and factors promoting the occurrence of vitamin D deficiency in the elderly. Postepy Hig Med Dosw (Online). 2017; 71(0):198-204. DOI: 10.5604/01.3001.0010.3804. View

Aludwan M, Kobyliak N, Abenavoli L, Kyriienko D, Fagoonee S, Pellicano R . Vitamin D3 deficiency is associated with more severe insulin resistance and metformin use in patients with type 2 diabetes. Minerva Endocrinol. 2020; 45(3):172-180. DOI: 10.23736/S0391-1977.20.03161-2. View

Infante M, Ricordi C, Sanchez J, Clare-Salzler M, Padilla N, Fuenmayor V . Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes. Nutrients. 2019; 11(9). PMC: 6769474. DOI: 10.3390/nu11092185. View

Dzik K, Kaczor J . Mechanisms of vitamin D on skeletal muscle function: oxidative stress, energy metabolism and anabolic state. Eur J Appl Physiol. 2019; 119(4):825-839. PMC: 6422984. DOI: 10.1007/s00421-019-04104-x. View

Sirajudeen S, Shah I, Menhali A . A Narrative Role of Vitamin D and Its Receptor: With Current Evidence on the Gastric Tissues. Int J Mol Sci. 2019; 20(15). PMC: 6695859. DOI: 10.3390/ijms20153832. View

Akimbekov N, Digel I, Sherelkhan D, Lutfor A, Razzaque M . Vitamin D and the Host-Gut Microbiome: A Brief Overview. Acta Histochem Cytochem. 2020; 53(3):33-42. PMC: 7322162. DOI: 10.1267/ahc.20011. View

Mondul A, Weinstein S, Layne T, Albanes D . Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges. Epidemiol Rev. 2017; 39(1):28-48. PMC: 5858034. DOI: 10.1093/epirev/mxx005. View

10.

Welsh J . Vitamin D and breast cancer: Past and present. J Steroid Biochem Mol Biol. 2017; 177:15-20. PMC: 5780261. DOI: 10.1016/j.jsbmb.2017.07.025. View

11.

Schroder-Heurich B, Springer C, von Versen-Hoynck F . Vitamin D Effects on the Immune System from Periconception through Pregnancy. Nutrients. 2020; 12(5). PMC: 7284509. DOI: 10.3390/nu12051432. View

12.

Barchetta I, Cimini F, Cavallo M . Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update. Nutrients. 2020; 12(11). PMC: 7693133. DOI: 10.3390/nu12113302. View

13.

Nitsa A, Toutouza M, Machairas N, Mariolis A, Philippou A, Koutsilieris M . Vitamin D in Cardiovascular Disease. In Vivo. 2018; 32(5):977-981. PMC: 6199603. DOI: 10.21873/invivo.11338. View

14.

Voulgaris N, Papanastasiou L, Piaditis G, Angelousi A, Kaltsas G, Mastorakos G . Vitamin D and aspects of female fertility. Hormones (Athens). 2017; 16(1):5-21. DOI: 10.14310/horm.2002.1715. View

15.

Fischer V, Haffner-Luntzer M, Amling M, Ignatius A . Calcium and vitamin D in bone fracture healing and post-traumatic bone turnover. Eur Cell Mater. 2018; 35:365-385. DOI: 10.22203/eCM.v035a25. View

16.

Bijelic R, Milicevic S, Balaban J . Risk Factors for Osteoporosis in Postmenopausal Women. Med Arch. 2017; 71(1):25-28. PMC: 5364787. DOI: 10.5455/medarh.2017.71.25-28. View

17.

Qaseem A, Forciea M, Denberg T, Barry M, Cooke M, Fitterman N . Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians. Ann Intern Med. 2017; 166(11):818-839. DOI: 10.7326/M15-1361. View

18.

McGregor N, Murat M, Elango J, Poulton I, Walker E, Crimeen-Irwin B . IL-6 exhibits both - and -signaling in osteocytes and osteoblasts, but only -signaling promotes bone formation and osteoclastogenesis. J Biol Chem. 2019; 294(19):7850-7863. PMC: 6514630. DOI: 10.1074/jbc.RA119.008074. View

19.

Yokota K . [Inflammation and osteoclasts]. Nihon Rinsho Meneki Gakkai Kaishi. 2017; 40(5):367-376. DOI: 10.2177/jsci.40.367. View

20.

Domazetovic V, Fontani F, Marcucci G, Iantomasi T, Brandi M, Vincenzini M . Estrogen inhibits starvation-induced apoptosis in osteocytes by a redox-independent process involving association of JNK and glutathione S-transferase P1-1. FEBS Open Bio. 2017; 7(5):705-718. PMC: 5407897. DOI: 10.1002/2211-5463.12216. View